• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.16% Nasdaq Up 0.25%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    8.92 Down 0.26(2.83%) Jun 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:9.18
    Open:9.20
    Bid:8.65 x 100
    Ask:9.15 x 500
    1y Target Est:9.29
    Beta:1.17
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:8.92 - 9.20
    52wk Range:4.90 - 9.89
    Volume:4,059,491
    Avg Vol (3m):5,177,290
    Market Cap:1.68B
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARIA

    Comparison

    Symbol% ChgMkt Cap
    ARIADown 2.83%1.68B
    NVSUp 0.54%249.97B
    PFEDown 0.55%212.81B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.72
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.08
    Quarterly EPS Est (Jun-15) :-0.27
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-0.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback